Executive Management and Proposed Board Changes

Paris, France and Camberley, UK – 5 January 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that James McCarthy has been appointed as Chief Financial Officer (CFO), whilst Anthony Dyer has taken on a new role as Chief Corporate Development Officer (CCDO). Both appointments are with immediate effect.

http://novacyt.com/wp-content/uploads/2021/01/Novacyt-Directorate-change-and-CFO-appointment-05.01.2021-ENG.pdf